{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 14,
        "end": 21
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 0,
        "end": 11
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 24,
        "end": 35
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 77,
        "end": 83
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 175,
        "end": 179
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 175,
        "end": 212
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27467210_4",
  "text": "Selumetinib ( AZD6244 , ARRY-142886 ) is a potent and selective inhibitor of MEK1/2 which has demonstrated significant efficacy in combination with docetaxel in patients with KRAS mutant pretreated advanced NSCLC ."
}
